Owlet, Inc.
OWLT-WT
New York Stock Exchange0.01
USD
+0.01
- -
CIK
0001816708
Return %
Stock
S&P500
1Y
-74.00
17.85
3Y
-74.00
64.56
5Y
-74.00
69.89
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- CIK
- 0001816708
- Similar Companies
- Business
- Owlet, Inc. (NYSE: OWLT) develops and markets a digital parenting platform offering FDA-authorized medical and consumer pediatric wearables, high-definition video monitors, and integrated software applications that provide parents with real-time data on infants' heart rate, oxygen levels, sleep patterns, and wellness metrics; core products include the Owlet Dream Sock and Dream Sock Plus for continuous pulse oximetry and sleep tracking suitable for infants up to 25 pounds or five months, Owlet Smart Sock for oxygen, heart rate, and sleep monitoring, Owlet Cam 1 and Cam 2 for HD video streaming with audio, Owlet Monitor Duo and Dream Duo bundles combining sock sensors with cameras for comprehensive health and visual oversight, the Owlet Sleeper wearable blanket to promote safe sleep for babies aged three to six months, and accessory items such as the Owlet Sock Travel Case, alongside the Owlet Dream Lab interactive program for building healthy sleep habits. Founded in 2012 and headquartered in Lehi, Utah, the company operates primarily in the United States, United Kingdom, European Union, and select international markets, targeting parents and caregivers concerned with infant health, safety, and sleep optimization within the medical devices and digital health segments of the healthcare industry. Recent developments include a major warrant exchange in August 2025 simplifying its capital structure by issuing 5.4 million common shares for Series A and B warrants with backing from 43% of shareholders including affiliates of CEO Kurt Workman and board member John Kim, a public offering of Class A common stock priced in October 2025 raising approximately $30 million in gross proceeds, a CEO transition plan announced alongside second quarter 2025 financial results reflecting 26% year-over-year revenue growth to $26.1 million and increased full-year guidance, expansion of Dream Sock availability in the European Union driving 98% international revenue growth in 2024 versus 2023, and recognition on Fast Company's 2025 Brands That Matter List for innovation in smart infant monitoring.